Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 21609748)

1.

Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru.

Penny M, Bartolini R, Mosqueira NR, LaMontagne DS, Mendoza MA, Ramos I, Winkler JL, Villafana J, Janmohamed A, Jumaan AO.

Vaccine. 2011 Jul 12;29(31):5022-30. doi: 10.1016/j.vaccine.2011.04.078. Epub 2011 May 24.

PMID:
21609748
2.

Parental acceptance of HPV vaccine in Peru: a decision framework.

Bartolini RM, Winkler JL, Penny ME, LaMontagne DS.

PLoS One. 2012;7(10):e48017. doi: 10.1371/journal.pone.0048017. Epub 2012 Oct 29.

3.

Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.

Watson M, Shaw D, Molchanoff L, McInnes C.

Aust N Z J Public Health. 2009 Aug;33(4):365-70. doi: 10.1111/j.1753-6405.2009.00409.x.

PMID:
19689598
4.

Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.

Vetter KM, Geller SE.

J Womens Health (Larchmt). 2007 Nov;16(9):1258-68. Review.

PMID:
18001182
5.

Formative research to shape HPV vaccine introduction strategies in Peru.

Bartolini RM, Drake JK, Creed-Kanashiro HM, Díaz-Otoya MM, Mosqueira-Lovón NR, Penny ME, Winkler JL, LaMontagne DS, Bingham A.

Salud Publica Mex. 2010 May-Jun;52(3):226-33.

6.

The school nurse, the school and HPV vaccination: a qualitative study of factors affecting HPV vaccine uptake.

Brabin L, Stretch R, Roberts SA, Elton P, Baxter D, McCann R.

Vaccine. 2011 Apr 12;29(17):3192-6. doi: 10.1016/j.vaccine.2011.02.038. Epub 2011 Feb 26.

PMID:
21354481
7.

Coverage from Ontario, Canada's school-based HPV vaccine program: the first three years.

Wilson SE, Harris T, Sethi P, Fediurek J, Macdonald L, Deeks SL.

Vaccine. 2013 Jan 21;31(5):757-62. doi: 10.1016/j.vaccine.2012.11.090. Epub 2012 Dec 13.

8.

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.

Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY.

Vaccine. 2008 Jul 29;26(32):4080-93. doi: 10.1016/j.vaccine.2008.04.053. Epub 2008 May 15.

PMID:
18550229
9.

Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.

Ault K, Reisinger K.

Int J Infect Dis. 2007 Nov;11 Suppl 2:S26-8. doi: 10.1016/S1201-9712(07)60018-6. Review.

10.

"Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination.

Cooper Robbins SC, Bernard D, McCaffery K, Brotherton J, Garland S, Skinner SR.

Vaccine. 2010 Apr 26;28(19):3398-408. doi: 10.1016/j.vaccine.2010.02.078. Epub 2010 Mar 1.

PMID:
20199758
11.

Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries.

LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S, Janmohamed A, Kumakech E, Mosqueira NR, Nguyen NQ, Paul P, Tang Y, Minh TH, Uttekar BP, Jumaan AO.

Bull World Health Organ. 2011 Nov 1;89(11):821-830B. doi: 10.2471/BLT.11.089862. Epub 2011 Sep 1.

12.

HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.

Castellsagué X, Schneider A, Kaufmann AM, Bosch FX.

Gynecol Oncol. 2009 Dec;115(3 Suppl):S15-23. doi: 10.1016/j.ygyno.2009.09.021. Epub 2009 Oct 12.

PMID:
19819540
13.

Assessment of eight HPV vaccination programs implemented in lowest income countries.

Ladner J, Besson MH, Hampshire R, Tapert L, Chirenje M, Saba J.

BMC Public Health. 2012 May 23;12:370. doi: 10.1186/1471-2458-12-370.

14.

Achieving high coverage in Rwanda's national human papillomavirus vaccination programme.

Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F.

Bull World Health Organ. 2012 Aug 1;90(8):623-8. doi: 10.2471/BLT.11.097253. Epub 2012 May 23.

15.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

16.

[Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].

Schneider A, Schwarz TF, Hammerschmidt T, Siebert U.

Med Klin (Munich). 2007 Jul 15;102(7):515-23. German.

PMID:
17634869
17.

Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program.

Paul P, Fabio A.

Vaccine. 2014 Jan 9;32(3):320-6. doi: 10.1016/j.vaccine.2013.11.070. Epub 2013 Dec 2. Review.

PMID:
24295804
18.

A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.

Dunne EF, Datta SD, E Markowitz L.

Cancer. 2008 Nov 15;113(10 Suppl):2995-3003. doi: 10.1002/cncr.23763. Review.

19.

The effect of school-based cervical cancer education on perceptions towards human papillomavirus vaccination among Hong Kong Chinese adolescent girls.

Kwan TT, Tam KF, Lee PW, Chan KK, Ngan HY.

Patient Educ Couns. 2011 Jul;84(1):118-22. doi: 10.1016/j.pec.2010.06.018. Epub 2010 Jul 21.

PMID:
20650592
20.

Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies.

Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D, Kapiga S, Mayaud P, de Sanjosé S, Wight D, Changalucha J, Hayes R.

J Infect Dis. 2012 Sep 1;206(5):678-86. doi: 10.1093/infdis/jis407. Epub 2012 Jun 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk